July 01, 2020 Go or no go? Pandemic looms over FDA timelines Approval decisions are due for Jazz, Gilead and Galapagos in July, while Glaxo is preparing for a panel.
July 02, 2018 June rush drives near-record quarter for biotech flotations Biotech IPOs raised a huge $2.3bn on Western exchanges in the second-quarter of 2018, as private companies rushed to market ahead of the summer lull.
